Default company panoramic image
Logo

Biocaldol Limited

Biocaldol's patented, 2nd generation, highly cost effective technology can transform the profitability and output of all bioethanol plants.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location GBK Restaurants Ltd, Lindsey Street, London, England, United Kingdom
  • Currency GBP
  • Founded February 2008
  • Employees 13
  • Website biocaldol.com

Company Summary

Biocaldol provides a low cost and highly attractive solution to bioethanol companies to increase the output, profitability and return on investment in their bioethanol plants. In addition it provides both the plants and their customers with bioethanol produced from 2nd generation technology. There is huge demand from both suppliers and users for low cost 2nd generation bioethanol due to increased legislation and growing demand.

Team

  • Default avatar
    James Edwards
    Mr

    James is the company's chief executive. He has extensive experience in the global chemical industry and a very strong track record of driving success in regional start ups and global manufacturing companies. James and his team have worked closely with Ensus over the last 3 years to use Biocaldol's technology and Ensus's bioethanol plant expertise to develop a highly attractive 2nd generation commercial solution for global bioethanol plants.

  • Default avatar
    Namdar Baghaei-Yazdi
    Dr

    Dr Baghaei-Yazdi is the company's Chief Technology Officer. He is an Imperial College graduate (PhD) with over 20 years experience and research into fermentation systems using thermophillic technology. Winner of the prestigious 1993 French Cereal Prize for his research on the thermophilic ethanol fermentation process, he is very highly regarded in the industry.

  • Default avatar
    Muhammad Javed
    Dr

    Dr Javed is the company's Chief Scientific Officer. He is an Imperial College graduate (PhD) with over 20 years post graduate experience in thermophillic technology. He is very highly regarded in this field with extensive experience in thermophillic strain isolation, strain screening, strain improvement, and fermentation studies of thermophilic micro organisms. Dr Javed is a co-author of a number of publications and patents.

  • Default avatar
    Malcolm Pearcey
    Mr

    Malcolm is the company's finance director. His experience includes finance director for a number of companies including Lotus Development (now part of IBM), SD Scicon (seeing growth from £1m to £300m - now part of EDS). For the past 10 years he has concentrated on start-ups in particular as part of a portfolio of clients. Having qualified as an accountant in 1977, Malcolm brings a wealth of experience at Board level to high growth companies.

Advisors

  • Default avatar
    Penningtons
    Lawyer
    Unconfirmed
    Default avatar
    Barnes Roffe
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Private investors, management and Ensus Ltd (World's largest wheat to bioethanol plant)
    Unconfirmed